Two Epstein-Barr virus-related serologic antibody tests in nasopharyngeal carcinoma screening: results from the initial phase of a cluster randomized controlled trial in Southern China.
about
Screening for nasopharyngeal cancerTherapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinomaEpstein-Barr virus antibodies and the risk of associated malignancies: review of the literatureEpstein-Barr virus serology as a potential screening marker for nasopharyngeal carcinoma among high-risk individuals from multiplex families in Taiwan.Nasopharyngeal Epstein-Barr Virus Load: An Efficient Supplementary Method for Population-Based Nasopharyngeal Carcinoma Screening.Incidence trend of nasopharyngeal carcinoma from 1987 to 2011 in Sihui County, Guangdong Province, South China: an age-period-cohort analysis.Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor originExpression of EBV antibody EA-IgA, Rta-IgG and VCA-IgA and SA in serum and the implication of combined assay in nasopharyngeal carcinoma diagnosis.Invited commentary: Epstein-Barr virus-based screening for the early detection of nasopharyngeal carcinoma: a new frontier.Evaluation of seven recombinant VCA-IgA ELISA kits for the diagnosis of nasopharyngeal carcinoma in China: a case-control trial.The role of oxidative stress in EBV lytic reactivation, radioresistance and the potential preventive and therapeutic implications.Cytolytic virus activation therapy and treatment monitoring for Epstein-Barr virus associated nasopharyngeal carcinoma in a mouse tumor model.Serum long non-coding RNAs MALAT1, AFAP1-AS1 and AL359062 as diagnostic and prognostic biomarkers for nasopharyngeal carcinoma.Sibship size, birth order and risk of nasopharyngeal carcinoma and infectious mononucleosis: a nationwide study in Sweden.Survival outcome of patients with nasopharyngeal carcinoma: a nationwide analysis of 13 407 patients in Taiwan.Evaluation of plasma Epstein-Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China.Nasopharyngeal carcinoma risk prediction via salivary detection of host and Epstein-Barr virus genetic variants.Liu et al. respond to "Epstein-Barr virus screening for nasopharyngeal carcinoma".Chemokine CCL27 is a novel plasma biomarker for identification the nasopharyngeal carcinoma patients from the Epstein-Barr virus capsid antigen-specific IgA seropositive population.Development of a population-based cancer case-control study in southern china.Epstein-Barr virus association with peptic ulcer disease.Establishment and validation of a two-step screening scheme for improved performance of serological screening of nasopharyngeal carcinoma.Nasopharyngeal carcinoma: A review of current updates.EBV based cancer prevention and therapy in nasopharyngeal carcinoma.Assessment of the Long-term Diagnostic Performance of a New Serological Screening Scheme in Large-scale Nasopharyngeal Carcinoma Screening.
P2860
Q24187937-0ED20EFE-59EE-495C-913C-140C618EECAEQ27016002-AE880605-8B06-4957-BC38-9783EDBD9399Q27021572-141B48B3-543A-474E-BE2E-0C1ACA1EA970Q33847952-8F8CDC49-1726-46D0-9324-5D7407923A2BQ34671337-03234A4E-2197-4F53-AB9E-924848D92803Q36121218-7DD53BAF-D681-47EA-8ADB-493E2FA25CCCQ36124331-BFBF7788-271F-4547-8B39-7419F662E33AQ36511863-46A450C7-70FD-47D8-9EC6-AA38AB1397A3Q36764940-1F926E58-830F-44C0-8CFF-82974983039DQ38663245-D9E13CDC-A832-4B73-9A88-BCFC12C95F3CQ39344275-FB302638-EF07-4C41-B51B-E18EED43A1E0Q40065361-E1E4269D-D1BB-4CAD-84ED-4EE7A8856546Q40228185-D53774D4-0CC0-467D-A4AE-E8F84AB62E33Q41272889-05D423E6-E183-47DC-8119-5E32FB866A13Q41592585-82351191-DB15-4405-BF29-8ED0A547F79FQ42240169-ABFFDD77-51C6-45F4-8073-B98DEAA2A2DEQ45323592-9547878F-58EF-470E-9089-23AFA5DF1660Q45353401-E870B958-8A49-4650-A3AB-53BCEDD90735Q47106227-92EA217D-1D6A-428C-8AEC-3F4E51B547B5Q47148245-07C3BCE8-3B91-4A3F-8C24-02DFBC232902Q50991183-DBF4AC00-8E59-4C63-AF9C-F5033098A373Q52685801-74695562-AA7B-4B3A-9A63-380C8EE2D8BBQ54252954-CB78E2D7-34E3-4782-A3E2-1C7DA6203FA0Q55003883-C44E5DE8-A41C-47BB-BAA9-2726C0D24CE3Q55280881-D3E9B53E-2FE1-42B7-AEEB-C14CD8FCF5A9
P2860
Two Epstein-Barr virus-related serologic antibody tests in nasopharyngeal carcinoma screening: results from the initial phase of a cluster randomized controlled trial in Southern China.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Two Epstein-Barr virus-related ...... olled trial in Southern China.
@en
Two Epstein-Barr virus-related ...... olled trial in Southern China.
@nl
type
label
Two Epstein-Barr virus-related ...... olled trial in Southern China.
@en
Two Epstein-Barr virus-related ...... olled trial in Southern China.
@nl
prefLabel
Two Epstein-Barr virus-related ...... olled trial in Southern China.
@en
Two Epstein-Barr virus-related ...... olled trial in Southern China.
@nl
P2093
P2860
P356
P1476
Two Epstein-Barr virus-related ...... rolled trial in Southern China
@en
P2093
Biao-Hua Wu
Er-Hong Lin
Hao-Yuan Mo
Kuang-Rong Wei
Ming-Huang Hong
Qi-Hong Huang
Shang-Hang Xie
Su-Mei Cao
P2860
P304
P356
10.1093/AJE/KWS404
P407
P577
2012-12-19T00:00:00Z